Clinical Trial Update: Descemet Endothelial Thickness Comparison Trial I [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for the Descemet Endothelial Thickness Comparison Trial I investigating Fuchs endothelial corneal dystrophy; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fuchs Endothelial Corneal Dystrophy

Snippet

Sponsor: Stanford University | Conditions: Fuchs | Phase 3 | Status: ACTIVE_NOT_RECRUITING